Skip to main content

Giménez Sanz, Noemí

Institutions of which they are part

Infection and immunity in pediatric patients
Vall Hebron Institut de Recerca

Giménez Sanz, Noemí

Institutions of which they are part

Infection and immunity in pediatric patients
Vall Hebron Institut de Recerca

Projects

RBDCOV: RBD Dimer recombinant protein vaccine against SARSCoV2

IP: Pere Soler Palacín
Collaborators: Miriam Gonzalez Amores, Tamara Del Rio Higueras, Ariadna Martín Balcells, Amaia Latasa Arrazubi, Noemí Giménez Sanz, Olga Sánchez- Maroto Carrizo, RBDCOV: RBD Dimer recombinant protein vaccine against SARSCoV2
Funding agency: EUROPEAN COMMISSION
Funding: 475000
Reference: RBDCOV_HE-HLTH-CORONA2021
Duration: 01/12/2021 - 31/05/2025

Related news

Members of the RBDCOV project, which involves VHIR, gathered at the Palau Macaya to review progress and achievements made during the final phase of the project.

During the meeting, the role of the Vall d'Hebron Paediatric Research Hub in promoting research on children and adolescents was highlighted.

The new technology allows more sensitive detection of scleroderma patients' autoantibodies, which are related to the severity and progression of the disease.

Related professionals

Ana Maria Rodriguez Arana

Ana Maria Rodriguez Arana

Main researcher
Molecular Medical Imaging
Read more
Laura Palau Triola

Laura Palau Triola

Research technician
Rheumatology
Read more
Patricia García Ortega

Patricia García Ortega

Research technician
Read more
Andreu Fernández Codina

Andreu Fernández Codina

Postdoctoral researcher
Rheumatology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.